Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.
Cloud Expo on Google News
SYS-CON.TV
Cloud Expo & Virtualization 2009 East
PLATINUM SPONSORS:
IBM
Smarter Business Solutions Through Dynamic Infrastructure
IBM
Smarter Insights: How the CIO Becomes a Hero Again
Microsoft
Windows Azure
GOLD SPONSORS:
Appsense
Why VDI?
CA
Maximizing the Business Value of Virtualization in Enterprise and Cloud Computing Environments
ExactTarget
Messaging in the Cloud - Email, SMS and Voice
Freedom OSS
Stairway to the Cloud
Sun
Sun's Incubation Platform: Helping Startups Serve the Enterprise
POWER PANELS:
Cloud Computing & Enterprise IT: Cost & Operational Benefits
How and Why is a Flexible IT Infrastructure the Key To the Future?
Click For 2008 West
Event Webcasts
Sanofi Pasteur MSD's Andrea Rappagliosi Appointed President of Vaccines Europe

LYON, France, January 14, 2013 /PRNewswire/ --


Appointment marks new chapter in vaccine advocacy in Europe

Andrea Rappagliosi, Vice President of Market Access, Health Policy & Medical Affairs at Sanofi Pasteur MSD has been appointed President of Vaccines Europe as of 1st January 2013.  

Vaccines Europe is the group representing vaccine manufacturers within the European Federation of Pharmaceutical Industries and Associations (EFPIA), the professional association of the European pharmaceutical industry. Its members include established vaccine companies such as Sanofi Pasteur MSD, AstraZeneca, Sanofi Pasteur, Novartis, GlaxoSmithKline Biologicals, Pfizer, Crucell, Abbott, Baxter and MSD.

Sanofi Pasteur MSD is one of the largest vaccines companies in Europe and Andrea Rappagliosi's appointment highlights the calibre and expertise of the new management team that has been brought in by Jean Paul Kress, President of Sanofi Pasteur MSD, since he took over the company in 2011.

"I am strongly supportive of Andrea's Presidency as it reflects our commitment to maintain and strengthen healthcare excellence in Europe for the benefit of people's health and wellbeing" said Jean-Paul Kress, President of Sanofi Pasteur MSD. "Andrea's expertise will boost Vaccines Europe's advocacy focus whilst highlighting Sanofi Pasteur MSD's profile as a clear leader in vaccines in Europe." 

With twenty years of experience in the pharmaceutical industry and a number of years within the Italian Institutions, Rappagliosi joined Sanofi Pasteur MSD from GlaxoSmithKline in 2012 as Vice President of Market Access, Health Policy & Medical Affairs.  

About Sanofi Pasteur MSD

Sanofi Pasteur MSD is a joint venture between Sanofi Pasteur, the vaccine division of Sanofi, and Merck, known as MSD outside the USA and Canada. Combining innovation and expertise, Sanofi Pasteur MSD is the only company in Europe dedicated exclusively to vaccines. Sanofi Pasteur MSD is able to draw on the research expertise of Sanofi Pasteur and Merck to focus on the development of new vaccines for Europe to improve the acceptability, efficacy and tolerability of vaccination.

About Vaccines Europe

Vaccines Europe (VE) is a specialized group within the European Federation of Pharmaceutical Industries and Associations (EFPIA), the professional association of the European pharmaceutical industry. Formed in 1991 under the name European Vaccines Manufacturers (EVM), the association set out to improve public health through immunization and promoting R&D of innovative vaccines, Vaccines Europe member companies are major manufacturers of vaccines worldwide, producing the majority of vaccine doses in Europe. VE members are: Abbott Biologicals, AstraZeneca, Baxter, Crucell, GlaxoSmithKline Biologicals, MSD, Novartis Vaccines, Pfizer, Sanofi Pasteur and Sanofi Pasteur MSD.

 


About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Cloud Developer Stories
Every successful software product evolves from an idea to an enterprise system. Notably, the same way is passed by the product owner's company. In his session at 20th Cloud Expo, Oleg Lola, CEO of MobiDev, will provide a generalized overview of the evolution of a software product...
SYS-CON Events announced today that Enzu will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY, and the 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the...
WebRTC services have already permeated corporate communications in the form of videoconferencing solutions. However, WebRTC has the potential of going beyond and catalyzing a new class of services providing more than calls with capabilities such as mass-scale real-time media broa...
Enterprise networks are complex. Moreover, they were designed and deployed to meet a specific set of business requirements at a specific point in time. But, the adoption of cloud services, new business applications and intensifying security policies, among other factors, require ...
Using new techniques of information modeling, indexing, and processing, new cloud-based systems can support cloud-based workloads previously not possible for high-throughput insurance, banking, and case-based applications. In his session at 18th Cloud Expo, John Newton, CTO, Fo...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021



SYS-CON Featured Whitepapers
ADS BY GOOGLE